Wells Fargo Initiates Coverage On Pharvaris with Overweight Rating, Announces Price Target of $55

Pharvaris N.V.

Pharvaris N.V.

PHVS

0.00

Wells Fargo analyst Yanan Zhu initiates coverage on Pharvaris (NASDAQ: PHVS) with a Overweight rating and announces Price Target of $55.